Bedside blood infection test being developed for sepsis

Blood poisoning (sepsis) is fast and frightening, and is one of the leading causes of death worldwide, killing up to half of its victims. Therefore, a bedside blood test, being developed by British researchers at the University of Liverpool, could allow early treatment, improving the outcomes and maybe even saving lives. Using a biomarker already validated by the group, the researchers are working with Sepsis Limited, a Liverpool-based company, to develop a rapid and robust point-of-care test that uses a drop of blood. The Technology Strategy Board (TSB) is supporting the £1.2 million (about $1.9 million) project. There are no reliable and rapid tests for sepsis, and as Dr. Enitan Carrol, from the University's Institute of Translational Medicine, said: "We want to help doctors make the appropriate clinical decision at the bedside, without having to wait for results from a laboratory." Release

Suggested Articles

The CE Mark for the system’s fourth iteration follows a July 2019 approval from the FDA.

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.